Cover Technologies Inc Stock Canadian Securities Exchange
Equities
HAVN
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 CAD | -13.46% | -26.76% | +52.94% |
Sales 2021 | - | Sales 2022 | 0.28 0.38 | Capitalization | 10.7M 14.66M |
---|---|---|---|---|---|
Net income 2021 | -30M -41.12M | Net income 2022 | -22M -30.16M | EV / Sales 2021 | - |
Net cash position 2021 | 8.95M 12.26M | Net cash position 2022 | 666K 913K | EV / Sales 2022 | 36,279,535 x |
P/E ratio 2021 |
-1.38
x | P/E ratio 2022 |
-0.4
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 96.5% |
1 day | -13.46% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Moore
CEO | Chief Executive Officer | 66 | 20-05-05 |
Jenna Pozar
COO | Chief Operating Officer | - | 21-02-28 |
Director/Board Member | - | 20-09-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Moore
CEO | Chief Executive Officer | 66 | 20-05-05 |
Ivan Casselman
BRD | Director/Board Member | - | - |
Director/Board Member | - | 20-09-03 |
1st Jan change | Capi. | |
---|---|---|
+0.98% | 43.84B | |
+5.33% | 41.68B | |
+45.32% | 41.25B | |
-10.92% | 27.04B | |
+6.77% | 25.53B | |
-25.42% | 18.18B | |
-3.96% | 12.29B | |
+25.66% | 12.29B | |
+7.17% | 11.15B |
- Stock Market
- Equities
- HAVN Stock
- HAVN Stock